Azelastine
Indications
Registered South African indications:
- Allergic rhinitis
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
Cautions
- Pregnancy
- Breastfeeding
Adult dosage
Forms avail. in SA and covered in this monograph: nas
Seasonal and perennial allergic rhinitis
- Nasal (nas): 0.14mg (1 actuation) per nostril, 12hrly
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: nas
Seasonal and perennial allergic rhinitis
Younger than 6 years
- Not established for use
Older than 6 years
- See adult dosage
Special populations
Pregnancy
- Caution
- At high oral doses in animals, 500 times the proposed oral human daily dose, foetal death, growth retardation and an increased incidence of skeletal abnormalities occurred during reproduction toxicity testing. Due to the nasal route of administration and the low dose administered, minimal systemic exposure can be expected. However as with all medicines caution should be exercised with use during pregnancy
Breastfeeding
- Caution
- Due to the nasal route of administration and the low dose administered, minimal systemic exposure can be expected. However as with all medicines caution should be exercised with use during breastfeeding
Fertility
- There is only limited data with regard to fertility
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warning
Adverse reactions
Respiratory Disorders
- Irritation of nasal mucousa
- Stinging
- Itching
- Sneezing
- Epistaxis
Gastrointestinal Disorders
- Bitter taste in mouth
- Nausea
Skin and Subcutaneous Tissue Disorders
- Rash
- Pruritis
- Urticaria
Interactions
No information available
Monitoring
None routine
Mechanism of action
Azelastine is a selective H1-receptor antagonist that inhibits release of histamine and other inflammatory mediators. It also increases motility of bronchial epithelial cilia, thus improving mucous clearance.
Dosage forms
- Nasal spray
Formulation
Nasal spray (per ml) 0.14mg
- Rhinolast (Mylan) originator
Also available in the following form: Eye drop
References
1. SmPC: Rhinolast Nasal Spray, Mylan Products Limited:Last updated on eMC: 29 May 2018; Downloaded online 13 Nov 2018 [https://drive.google.com/drive/u/0/folders/1euMPdGSf959_b9mnjQm6RmnIHaskIx8-] 2. Drugs.com: Azelastine; Downloaded online 13 Nov 2018 [https://drive.google.com/drive/u/0/folders/1euMPdGSf959_b9mnjQm6RmnIHaskIx8-] 3. PI: Rhinolast Nasal Spray, Meda Pharma SA (Pty) Ltd:Date of registration 17 Feb 1997 [https://drive.google.com/drive/u/0/folders/1euMPdGSf959_b9mnjQm6RmnIHaskIx8-] 4. https://www.uptodate.com/contents/azelastine-nasal-drug-information?source=search_result&search=azelastine&selectedTitle=1~21 (last accessed 18/12/2018) 5. NAPOS The Drug Database for Acute Porphyria: R01AC03 Azelastine; Accessed online 18 Dec 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=R01AC03&l=gbr] 6. South African Institute for Drug-Free Sport; Rhinolast; Accessed online 18 Dec 2018 [http://www.drugfreesport.org.za/online-medication-check/] 7. SmPC: Dymista 137 micrograms/ 50 micrograms per actuation Nasal Spray, Mylan; Last updated on eMC: 10 Dec 2019; Downloaded online: 05 May 2020 [https://www.medicines.org.uk/emc/product/9450/smpc/print]
Brands & products
1 product · cached snapshot- Rhinolast
NASNasal spray· 1 product
from R95.20| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Rhinolast Nasal Spray | 0.14 mg/ml | 10 | Mylan (Pty) Ltd | R95.20 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.